Lixte Biotechnology Holdings Inc
PEP-Therapy SAS
Re-Pharm Ltd
SupremeCure Pharma Inc
Velacor Therapeutics Pty Ltd
Published | Pages | Publisher | Report code |
---|---|---|---|
Dec 2019 | 51 | Global Markets Direct | ASDR-503289 |
Lixte Biotechnology Holdings Inc
PEP-Therapy SAS
Re-Pharm Ltd
SupremeCure Pharma Inc
Velacor Therapeutics Pty Ltd